Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis

Objectives This post-hoc analysis explored the impact of body mass index (BMI) on tofacitinib efficacy/safety in patients with active psoriatic arthritis (PsA).Methods Data were pooled from two phase 3 studies (NCT01877668; NCT01882439). Analyses included patients randomised to tofacitinib 5/10 mg...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Daniela Graham, Philip S Helliwell, Christopher Ritchlin, Alexis Ogdie, Jon T Giles, Rebecca Germino, Lori Stockert, Pamela Young, Wael Joseph, Rajiv Mundayat, Juan J Gómez-Reino
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2021-04-01
coleção:	RMD Open
Acesso em linha:	https://rmdopen.bmj.com/content/7/1/e001486.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!